首页 | 本学科首页   官方微博 | 高级检索  
检索        

CA19-9、增强MRI和PET/CT在胰腺癌诊断及分期中的价值
引用本文:王治国,石庆学,郭佳,左峰,吴锐先,张宗鹏,张国旭.CA19-9、增强MRI和PET/CT在胰腺癌诊断及分期中的价值[J].标记免疫分析与临床,2014,21(5):507-510.
作者姓名:王治国  石庆学  郭佳  左峰  吴锐先  张宗鹏  张国旭
作者单位:沈阳军区总医院核医学科,辽宁沈阳,110840;沈阳军区总医院核医学科,辽宁沈阳,110840;沈阳军区总医院核医学科,辽宁沈阳,110840;沈阳军区总医院核医学科,辽宁沈阳,110840;沈阳军区总医院核医学科,辽宁沈阳,110840;沈阳军区总医院核医学科,辽宁沈阳,110840;沈阳军区总医院核医学科,辽宁沈阳,110840
摘    要:目的探讨CA19-9、增强MRI和PET/CT在胰腺癌诊断及分期中的价值。方法回顾性分析沈阳军区总医院普外科2013年1月至2014年1月间收治的92例手术治疗的胰腺占位患者资料。患者术前均行CA19-9检查、腹部增强MRI扫描及全身PET/CT扫描,以术后病理或临床综合评价诊断为标准,比较CA19-9、增强MRI和PET/CT在胰腺癌诊断及分期中的价值。结果 92例患者中,确诊胰腺癌82例,非胰腺癌10例。CA19-9检查、腹部增强MRI及全身PET/CT对胰腺癌诊断的灵敏度分别为78.0%、86.6%和92.7%。PET/CT具有较高灵敏度,显著优于CA19-9,差异有统计学意义(P=0.008);PET/CT优于增强MRI,差异无统计学意义(P=0.200);在胰周淋巴结转移判断方面,增强MRI和PET/CT的灵敏度分别为46.9%、81.6%,二者差异有统计学意义(P〈0.001);在肝转移判断方面,增强MRI和PET/CT诊断的灵敏度分别为54.5%、72.7%,二者差异无统计学意义(P=0.66)。结论PET/CT对胰腺癌诊断有较高灵敏度,优于CA19-9、增强MRI;PET/CT有助于发现淋巴结和远处器官转移病灶,获得更加准确的术前分期,从而避免诊断性剖腹探查手术。由于仍然存在假阴性、假阳性,应该综合其他检查方法对疾病作全面分析来提高临床诊断准确性。

关 键 词:胰腺癌  CA19-9  增强MRI  PET/CT

Clinical Value of CA19-9, Contrast-enhanced MRI and PET-CT in the Diagnosis and Staging of Pancreatic Cancer
WANG Zhi-guo,SHI Qing-xue,GUO Jia,ZUO Feng,WU Rui-xian,ZHANG Zong-peng,ZHANG Guo-xu.Clinical Value of CA19-9, Contrast-enhanced MRI and PET-CT in the Diagnosis and Staging of Pancreatic Cancer[J].Labeled Immunoassays and Clinical Medicine,2014,21(5):507-510.
Authors:WANG Zhi-guo  SHI Qing-xue  GUO Jia  ZUO Feng  WU Rui-xian  ZHANG Zong-peng  ZHANG Guo-xu
Institution:WANG Zhi- guo, SHI Qing- xue, GUO Jia, ZUO Feng, WU Rui- xian, ZHANG Zong- peng, ZHANG Guo- xu (Department of Nuclear Medicine, General Hospital of Shenyang Military Area Command, Shenyang 110840, China)
Abstract:Objective To investigate the CA19-9, enhanced MRI and PET-CT value in the diagnosis and staging of pancreatic cancer. Methods A retrospective analysis of 92 patients with pancreatic placeholder admitted in our hospital was carried out. Preoperative CA19-9 inspection, abdominal enhanced MRI scans and whole body PET-CT scan were performed. The clinical value of CA19-9, enhanced MRI and PET-CT in the diagnosis and staging of pancreatic cancer were evaluated. Results Among 92 patients, 82 cases were diagnosed with pancreatic cancer and 10 cases with non-pancreatic cancer. The sensitivity of CA19-9 inspection, abdominal enhanced MRI and whole body PET-CT for the diagnosis of pancreatic cancer were 78.0%, 86.6% and 92.7% respectively. PET-CT had a higher sensitivity and better than CA19-9 (P 〈 0.01). PET-CT was superior to enhanced MRI but no statistically significant (P = 0. 200). The sensitivity of enhanced MRI and PET-CT in the judgment of peripancreatic lymph node metastasis were 46.9% and 81.6% (P 〈0.001 ). The sensitivity of enhanced MRI and PET-CT in diagnosis of liver metastases were 54.5% and 72.7% without statistically significant ( P = 0.66). PET- CT in the diagnosis of pancreatic cancer had a higher sensitivity than CA19-9 and enhanced MRI. Conclusion PET-CT could help to find the lymph nodes and distant organs metastasis, to obtain a more accurate preoperative staging, thus avoiding diagnostic laparotomy exploratory surgery. There is still false negative and false positive result for PET-CT, the comprehensive analysis of all inspection method results should be carried out to improve clinical diagnosis accuracy.
Keywords:Pancreatic cancer  CA19-9  Contrast-enhanced MRI  PET-CT
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号